Sreekanth Sreekantam1, Trystan Macdonald2, Pearse A Keane3, Dawn A Sim3, Philip I Murray1,4, Alastair K Denniston2,4. 1. Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK. 2. Department of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 3. NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK. 4. Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Abstract
BACKGROUND/AIMS: To evaluate the vitreous signals obtained on spectral domain optical coherence tomography (SD-OCT) in patients with uveitic cystoid macular oedema (CMO) and compare these signals before and after sub-Tenon's triamcinolone acetonide injection. METHODS: Retrospective study with standardised longitudinal imaging preintervention and postintervention. The study cohort comprises 22 patients (22 eyes) with uveitic CMO receiving a sub-Tenon's triamcinolone acetonide (STTA) injection. Post hoc analysis of SD-OCT images using custom software provided an 'absolute' measurement of vitreous signal intensity, which was expressed as a ratio to the retinal pigment epithelium intensity ('VIT/RPE-relative intensity') in arbitrary units. MAIN OUTCOME MEASURE: Difference in VIT/RPE-relative intensity before and after treatment. RESULTS: Treatment with STTA resulted in a significant reduction in VIT/RPE-relative intensity, which was associated with both a reduction in central retinal thickness (CRT) and improvement in visual acuity. Mean (SD) VIT/RPE-relative intensity pretreatment was 0.139 (0.074) versus 0.053 (0.028) post-treatment (p=3×10-5). Mean (SD) CRT was 581 μm (119 μm) pretreatment versus 333 μm (95 μm) post-treatment (p=2×10-8); the mean reduction in CRT was 248 (95% CI 189 to 306). The correlation coefficient between VIT/RPE-relative intensity and CRT was 0.534 (p=0.011) and between VIT/RPE-relative intensity and visual acuity was 0.702 (p=0.0001). CONCLUSIONS: This study provides evidence that the OCT-derived VIT/RPE-relative intensity may be useful as a quantitative and objective marker of disease activity and treatment response in uveitis complicated by CMO. This first longitudinal study of this novel OCT parameter is an encouraging step in the development of sensitive objective OCT-based endpoints for trials of efficacy in uveitis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND/AIMS: To evaluate the vitreous signals obtained on spectral domain optical coherence tomography (SD-OCT) in patients with uveitic cystoid macular oedema (CMO) and compare these signals before and after sub-Tenon's triamcinolone acetonide injection. METHODS: Retrospective study with standardised longitudinal imaging preintervention and postintervention. The study cohort comprises 22 patients (22 eyes) with uveitic CMO receiving a sub-Tenon's triamcinolone acetonide (STTA) injection. Post hoc analysis of SD-OCT images using custom software provided an 'absolute' measurement of vitreous signal intensity, which was expressed as a ratio to the retinal pigment epithelium intensity ('VIT/RPE-relative intensity') in arbitrary units. MAIN OUTCOME MEASURE: Difference in VIT/RPE-relative intensity before and after treatment. RESULTS: Treatment with STTA resulted in a significant reduction in VIT/RPE-relative intensity, which was associated with both a reduction in central retinal thickness (CRT) and improvement in visual acuity. Mean (SD) VIT/RPE-relative intensity pretreatment was 0.139 (0.074) versus 0.053 (0.028) post-treatment (p=3×10-5). Mean (SD) CRT was 581 μm (119 μm) pretreatment versus 333 μm (95 μm) post-treatment (p=2×10-8); the mean reduction in CRT was 248 (95% CI 189 to 306). The correlation coefficient between VIT/RPE-relative intensity and CRT was 0.534 (p=0.011) and between VIT/RPE-relative intensity and visual acuity was 0.702 (p=0.0001). CONCLUSIONS: This study provides evidence that the OCT-derived VIT/RPE-relative intensity may be useful as a quantitative and objective marker of disease activity and treatment response in uveitis complicated by CMO. This first longitudinal study of this novel OCT parameter is an encouraging step in the development of sensitive objective OCT-based endpoints for trials of efficacy in uveitis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Maria Jesus Rodrigo; Amaya Pérez Del Palomar; Alberto Montolío; Silvia Mendez-Martinez; Manuel Subias; Maria Jose Cardiel; Teresa Martinez-Rincon; José Cegoñino; José Maria Fraile; Eugenio Vispe; José Antonio Mayoral; Vicente Polo; Elena Garcia-Martin Journal: Pharmaceutics Date: 2021-02-05 Impact factor: 6.321
Authors: Xiaoxuan Liu; Aditya U Kale; Giovanni Ometto; Giovanni Montesano; Alice J Sitch; Nicholas Capewell; Charlotte Radovanovic; Nicholas Bucknall; Nicholas A V Beare; David J Moore; Pearse A Keane; David P Crabb; Alastair K Denniston Journal: Transl Vis Sci Technol Date: 2022-01-03 Impact factor: 3.283
Authors: G Montesano; C M Way; G Ometto; H Ibrahim; P R Jones; R Carmichael; X Liu; T Aslam; P A Keane; D P Crabb; A K Denniston Journal: Sci Rep Date: 2018-01-26 Impact factor: 4.379
Authors: María Jesús Rodrigo; Manuel Subías; Alberto Montolío; Silvia Méndez-Martínez; Teresa Martínez-Rincón; Lorena Arias; David García-Herranz; Irene Bravo-Osuna; Julian Garcia-Feijoo; Luis Pablo; José Cegoñino; Rocio Herrero-Vanrell; Ana Carretero; Jesus Ruberte; Elena Garcia-Martin; Amaya Pérez Del Palomar Journal: Biomedicines Date: 2021-11-29
Authors: Xiaoxuan Liu; Benjamin Tk Hui; Christopher Way; Sophie Beese; Ada Adriano; Pearse A Keane; David J Moore; Alastair K Denniston Journal: Ocul Immunol Inflamm Date: 2020-10-06 Impact factor: 3.070